Literature DB >> 16845708

Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality.

Andrea Becker-Merok1, Hans C Nossent.   

Abstract

OBJECTIVE: To describe damage accrual and the interconnections between disease activity measures, damage accrual, and death in a Nordic lupus cohort.
METHODS: Longitudinal study in the population-based Tromso lupus cohort. Disease activity [SLE Disease Activity Index (SLEDAI)] and disease damage [by Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI)] were recorded for each visit. Weighted average SLEDAI scores (WAS) were calculated to correct for variable observation times. Development of damage (SDI > 0), severe damage (SDI >or= 3), and death were used as separate endpoints. Univariate nonparametric analysis identified and hazard ratios (HR) by Cox regression techniques confirmed the independence of predictors for each outcome.
RESULTS: Through 11.9 years of followup, 72 patients (46%) remained free of damage, 51 (32%) developed moderate damage, and 35 (22%) developed severe damage. SDI scores were higher in 37 nonsurvivors (23.4%; SDI 2.1) than in survivors (SDI 0.9; p < 0.05). Damage accrual was linear throughout the first decade of disease. The only independent predictor for SDI >/= 3 was a WAS score > 3 (hazard ratio 2.34; 95% CI 1.1-4.9). Age > 40 years at diagnosis (HR 5.6, 95% CI 2.4-12.7) and WAS > 3 (HR 2.4, 95% CI 1.2-4.9) were significant predictors for death.
CONCLUSION: Damage accrual in SLE occurred in 54% of patients in a linear fashion over the first decade of disease. Global disease activity was the main determinant of damage accrual. Accrued damage was not an independent risk factor for death, which was predicted by age > 40 years and WAS > 3.

Entities:  

Mesh:

Year:  2006        PMID: 16845708

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  27 in total

1.  Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus?

Authors:  Rina Mina; Hermine I Brunner
Journal:  Rheum Dis Clin North Am       Date:  2010-02       Impact factor: 2.670

2.  Impact of the longitudinal quantitative assessment of juvenile systemic lupus erythematosus severity on the disease outcome.

Authors:  Maria Trachana; Polyxeni Pratsidou-Gertsi; Florence Kanakoudi-Tsakalidou; Vasiliki Tzimouli; Nikoleta Printza; Fotis Papachristou
Journal:  Clin Rheumatol       Date:  2020-07-07       Impact factor: 2.980

Review 3.  A review on SLE and malignancy.

Authors:  May Y Choi; Kelsey Flood; Sasha Bernatsky; Rosalind Ramsey-Goldman; Ann E Clarke
Journal:  Best Pract Res Clin Rheumatol       Date:  2017-11-10       Impact factor: 4.098

4.  Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus.

Authors:  Tünde Tarr; Gábor Papp; Nikolett Nagy; Edina Cserép; Margit Zeher
Journal:  Clin Rheumatol       Date:  2016-11-26       Impact factor: 2.980

Review 5.  Update on Antiphospholipid Syndrome: Ten Topics in 2017.

Authors:  Ilaria Cavazzana; Laura Andreoli; Maarteen Limper; Franco Franceschini; Angela Tincani
Journal:  Curr Rheumatol Rep       Date:  2018-03-15       Impact factor: 4.592

Review 6.  Clinical perspectives on lupus genetics: advances and opportunities.

Authors:  Judith A James
Journal:  Rheum Dis Clin North Am       Date:  2014-06-10       Impact factor: 2.670

7.  Systemic lupus erythaematosus in a multiethnic US cohort (LUMINA) LIII: disease expression and outcome in acute onset lupus.

Authors:  A M Bertoli; L M Vilá; J D Reveille; G S Alarcón
Journal:  Ann Rheum Dis       Date:  2007-08-24       Impact factor: 19.103

8.  Disease features and outcomes in United States lupus patients of Hispanic origin and their Mestizo counterparts in Latin America: a commentary.

Authors:  Manuel F Ugarte-Gil; Guillermo J Pons-Estel; Julio Molineros; Daniel Wojdyla; Gerald McGwin; Swapan K Nath; Bernardo A Pons-Estel; Marta Alarcón-Riquelme; Graciela S Alarcón
Journal:  Rheumatology (Oxford)       Date:  2015-09-27       Impact factor: 7.580

9.  Long-term prognosis and factors associated with damage accrual in Japanese patients with systemic lupus erythematosus.

Authors:  Yoko Wada; Hisashi Hasegawa; Takako Saeki; Satoshi Ito; Takeshi Kuroda; Masaaki Nakano; Ichiei Narita
Journal:  Clin Exp Nephrol       Date:  2017-10-25       Impact factor: 2.801

10.  High-sensitivity C-reactive protein as an associate of clinical subsets and organ damage in systemic lupus erythematosus.

Authors:  Shin-Seok Lee; Sukhminder Singh; Kimberly Link; Michelle Petri
Journal:  Semin Arthritis Rheum       Date:  2008-01-25       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.